Parexel acquires D.C. area health care consulting firm State & Federal Associates.
PAREXEL ACQUISITION OF STATE & FEDERAL ASSOCIATES HEALTH CARE CONSULTING firm will provide the Waltham, Mass.-based contract research organization with the ability to provide a full range of services, including "front-end strategic consulting," Parexel said Aug. 22. S&FA and Parexel combined also will offer "clinical research focusing on product safety and efficacy, pre- and post-launch marketing initiatives, economic modeling throughout the process, and outcomes research encompassing clinical, economic and quality-of-life issues," Parexel said.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth